Axsome Therapeutics, Inc.AXSMNASDAQ
LOADING
|||
Switch Symbol:
Revenue Growth Under Pressure
Trending lower.
Left:
||||
Year-over-year revenue growth rate
Latest
13.96%
Near historical average
Average (39q)
12.88%
Historical baseline
Range
High:288.06%
Low:-50.62%
Volatility
2630.4%
High variability
| Period | Value |
|---|---|
| Q3 2025 | 13.96% |
| Q2 2025 | 23.53% |
| Q1 2025 | 2.27% |
| Q4 2024 | 13.37% |
| Q3 2024 | 20.19% |
| Q2 2024 | 16.22% |
| Q1 2024 | 4.85% |
| Q4 2023 | 23.77% |
| Q3 2023 | 23.76% |
| Q2 2023 | -50.62% |
| Q1 2023 | 288.06% |
| Q4 2022 | 44.67% |
| Q3 2022 | 91.00% |
| Q2 2022 | 0.00% |
| Q1 2022 | 0.00% |
| Q4 2021 | 0.00% |
| Q3 2021 | 0.00% |
| Q2 2021 | 0.00% |
| Q1 2021 | 0.00% |
| Q4 2020 | 0.00% |
| Q3 2020 | 0.00% |
| Q2 2020 | 0.00% |
| Q1 2020 | 0.00% |
| Q4 2019 | 0.00% |
| Q3 2019 | 0.00% |
| Q2 2019 | 0.00% |
| Q1 2019 | 0.00% |
| Q4 2018 | 0.00% |
| Q3 2018 | 0.00% |
| Q2 2018 | 0.00% |
| Q1 2018 | 0.00% |
| Q4 2017 | 0.00% |
| Q3 2017 | 0.00% |
| Q2 2017 | 0.00% |
| Q1 2017 | 0.00% |
| Q4 2016 | 0.00% |
| Q3 2016 | 0.00% |
| Q2 2016 | 0.00% |
| Q1 2016 | 0.00% |
| Q4 2015 | 0.00% |